Updated on 11 Aug 2026, 02:29 AM IST
|
| ||||
|
| ||||
Names | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 1,952.75 | 0.19 | 4,68,519.10 | 38.40 | 5.55 | 0.83 | 0.47 |
| Divi's Laboratories | 8,275.00 | 0.32 | 2,19,675.25 | 73.32 | 11.48 | 0.41 | 0.03 |
| Torrent Pharmaceuticals | 4,915.50 | -0.74 | 1,88,510.30 | 72.73 | 19.22 | 0.80 | 141.16 |
| Cipla | 1,460.00 | -0.82 | 1,17,945.42 | 27.57 | 3.33 | 0.92 | 1.11 |
| Zydus Lifesciences | 1,120.70 | 0.49 | 1,11,790.26 | 21.19 | 4.24 | 0.09 | 14.22 |
| Meeting Date | Purpose |
|---|---|
| 2026-06-18 | Issue Of Warrants |
| 2026-05-21 | Others |
| 2026-05-15 | Others |
| 2026-04-30 | Audited Results |
| 2026-01-28 | Quarterly Results |
Sudarshan Pharma Industries is trading at 32.30 as on Mon Aug 10 2026 09:57:52. This is -5.00% lower as compared to its previous closing price of 34.00.
The market capitalization of Sudarshan Pharma Industries is 777.33 Cr as on Mon Aug 10 2026 09:57:52.
The 52 wk high for Sudarshan Pharma Industries is 42.79 whereas the 52 wk low is 18.50
Sudarshan Pharma Industries can be analyzed on the following key metrics -
Sudarshan Pharma Industries reported a net profit of 23.30 Cr in 2026.
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.